KTTA average generic catalyst stock move?

For "KTTA average generic catalyst stock move": across 3 resolved past events on file, KTTA saw a median absolute move of ~17.3% to the outcome date, with price often settling inside the prior scenario band (backward-looking only). See the historical catalyst schedule on Scouter for KTTA (past outcomes only; forward bull/bear targets unlock with a Starter or Premium free trial).

KTTA (Pasithea Therapeutics Corp.) — Stock Analysis, Catalysts & AI Research

Pasithea Therapeutics Corp.

$0.56

Health CareBiotechnology

The Read: KTTA's stock historically reacted with a median absolute move of ~17%.

KTTA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Pasithea Therapeutics Corp.

$0.56

Health CareBiotechnology

The Read: KTTA's stock historically reacted with a median absolute move of ~17%.

KTTA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Start your free trial to unlock active Expected Moves for KTTA

Expected Moves

Pasithea Therapeutics Corp.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Start your free trial to unlock active Expected Moves for KTTA

Expected Moves

Pasithea Therapeutics Corp.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow